150 results on '"Kong, George"'
Search Results
2. Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial
3. Two-year outcomes of Xen 45 gel stent implantation in patients with open-angle glaucoma: real-world data from the Fight Glaucoma Blindness registry.
4. Performance of a Deep Learning System and Performance of Optometrists for the Detection of Glaucomatous Optic Neuropathy Using Colour Retinal Photographs.
5. The Short-Term Compliance and Concordance to in Clinic Testing for Tablet-Based Home Monitoring in Age-Related Macular Degeneration
6. Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator’s Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III Trial
7. How to Reduce Error in Optic Nerve Head Examination
8. A randomized, controlled, multicenter, phase 3 study of vusolimogene oderparepvec (VO) combined with nivolumab vs treatment of physician’s choice in patients with advanced melanoma that has progressed on anti–PD-1 and anti–CTLA-4 therapy (IGNYTE-3).
9. Measuring Visual Fields in Children With Glaucoma Using a Portable Tablet
10. Safety, Patient-Reported Well-Being, and Physician-Reported Assessment of Walking Ability in Patients with Multiple Sclerosis for Prolonged-Release Fampridine Treatment in Routine Clinical Practice: Results of the LIBERATE Study
11. Uptake, Persistence, and Performance of Weekly Home Monitoring of Visual Field in a Large Cohort of Patients With Glaucoma
12. LP-184 Rationale and design of two phase 3, Randomized, double-blind, placebo-controlled studies of the efficacy and safety of litifilimab in adults with active systemic lupus erythematosus: TOPAZ-1 and TOPAZ-2
13. Progressive multifocal leukoencephalopathy with natalizumab extended or standard interval dosing in the United States and the rest of the world
14. Daclatasvir and Peginterferon/Ribavirin for Black/African-American and Latino Patients with HCV infection
15. Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial
16. Performance of a Smart Device over 12-Months for Home Monitoring of Patients with Intermediate Age-Related Macular Degeneration
17. Extended-interval dosing of natalizumab in NOVA – Authors' reply
18. Visual fields in glaucoma: Where are we now?
19. Neuroprotection of retinal ganglion cells by a novel gene therapy construct that achieves sustained enhancement of brain-derived neurotrophic factor/tropomyosin-related kinase receptor-B signaling
20. Independent radiologic review of the Gynecologic Oncology Group Study 0218, a phase III trial of bevacizumab in the primary treatment of advanced epithelial ovarian, primary peritoneal, or fallopian tube cancer
21. Estimating the survival functions for right-censored and interval-censored data with piecewise constant hazard functions
22. Test Reliability and Compliance to a Twelve-Month Visual Field Telemedicine Study in Glaucoma Patients
23. Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial
24. Primary Results of NOVA: a Randomized Controlled Study of the Efficacy of 6 - Week Dosing of Natalizumab Versus Continued 4-Week Treatment for Multiple Sclerosis (S14.005)
25. Primary Results of NOVA: A Randomized Controlled Study of the Efficacy of 6 Week Dosing of Natalizumab Versus Continued 4-Week Treatment for Multiple Sclerosis
26. Optic Disc Evaluation in Optic Neuropathies: The Optic Disc Assessment Project
27. Mitochondrial dysfunction in glaucoma and emerging bioenergetic therapies
28. Résultats primaires de NOVA : une étude contrôlée randomisée comparant l’administration de natalizumab toutes les 6 semaines versus une administration continue toutes les 4 semaines dans le traitement de la sclérose en plaques
29. Screening for Glaucomatous Visual Field Defects in Rural Australia with an iPad
30. 8. RISK FACTORS FOR RETINAL REDETACHMENT FOLLOWING INITIAL RETINAL DETACHMENT REPAIR ASSOCIATED WITH OPEN-GLOBE INJURY: 2408
31. 1. Using an Ipad Device to Test the Visual Fields of Patients with Neuro\Ophthalmic Diseases: 0901
32. 1. Comparison Between Surgical Outcomes of Glaucoma Drainage Device Surgeries Performed With and Without Intraluminal Stent
33. Wound-related complications and clinical outcomes following open globe injury repair
34. 10. THE SCOTOPIC THRESHOLD RESPONSE (STR) AND PHOTOPIC NEGATIVE RESPONSE (PHNR) IN GLAUCOMA PATIENTS AND NORMALS: 1810
35. TRACKING CLINICIAN EYE MOVEMENT IN OPTIC DISC EXAMINATION: 9.
36. MITOCHONDRIAL IMPAIRMENT RESULTS IN INCREASED SUSCEPTIBILITY TO INJURY IN RETINAL NEURONS: 8.
37. WHY IS THE DISC MISSED? - LESSONS FROM THE GONE PROJECT: 5.
38. THE EYEPRESSURE SOFTWARE - A NEW GLAUCOMA MANAGEMENT TOOL FOR CLINICIANS: 6.
39. The effect of different doses of intracameral bevacizumab on surgical outcomes of trabeculectomy for neovascular glaucoma
40. A novel HIV-1 antiviral high throughput screening approach for the discovery of HIV-1 inhibitors
41. Should this artificial intelligence algorithm be used in my practice now? A checklist approach: Response.
42. Novel Means of Clinical Visual Function Testing among Glaucoma Patients, Including Virtual Reality
43. An open-label, phase 2 study of nivolumab in combination with either rucaparib, docetaxel, or enzalutamide in men with castration-resistant metastatic prostate cancer (mCRPC; CheckMate 9KD).
44. Tablets at the bedside - iPad-based visual field test used in the diagnosis of Intrasellar Haemangiopericytoma: a case report
45. Glaucoma.
46. A Novel Method of Quantitative Anterior Chamber Depth Estimation Using Temporal Perpendicular Digital Photography
47. Validation of a Tablet as a Tangent Perimeter
48. Anti-PEG antibody bioanalysis: a clinical case study with PEG-IFN-λ-1a and PEG-IFN-α2a in naive patients
49. Using Mobile Tethering for sharing data across devices: application in rural eye screening
50. High speed 650V IGBTs for DC-DC conversion up to 200 kHz
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.